114. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE 1997Effect of calcium and vitamin d supplementation on bonedensity in men and women 65 years of age or older. n engl JMed 337:670–676115. Schott GD, Wills MR 1976 Muscle weakness in osteomalacia.Lancet 1:626–629116. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y,Karlson EW, Dawson-Hughes B 2004 Higher 25-hydroxyvitamind concentrations are associated with better lowerextremityfunction in both active and inactive persons agedor 60 y. Am J Clin Nutr 80:752–758117. Pfeifer M, Begerow B, Minne HW, Abrams C, NachtigallD, Hansen C 2000 effects of a short-term vitamin d andcalcium supplementation on body sway and secondaryhyperparathyroidism in elderly women. J Bone Miner Res15:1113–1118126. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL,Peterson J, Saltzman E, Dawson-Hughes B 2008 <strong>Vitamin</strong>D( 3) in fat tissue. Endocrine 33:90–94127. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-LuxMJ 2003 Human serum 25-hydroxycholecalciferol responseto extended oral dosing with cholecalciferol. am J Clin nutr77:204–210128. Biancuzzo RM, Young A, Bibuld D, Cai MH, Winter MR,Klein EK, Ameri A, Reitz R, Salameh W, Chen TC, HolickMF 2010 Fortification of orange juice with vitamin d 2or vitamin d 3is as effective as an oral supplement inmaintaining vitamin d status in adults. am J Clin nutr91:1621–1626129. Armas LA, Hollis BW, Heaney RP 2004 <strong>Vitamin</strong> d 2is muchless effective than vitamin d3 in humans. J Clin endocrinolMetab 89:5387–5391A n E n d o c r i n e S o c i e t y C l i n i c a l P r a c t i c e G u i d e l i n e118. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H 2009 effects of a long-term vitamin dand calcium supplementation on falls and parameters ofmuscle function in community-dwelling older individuals.Osteoporos Int 20:315–322119. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA,Holick MF, Kiel DP 2007 a higher dose of vitamin d reducesthe risk of falls in nursing home residents: a randomized,multiple-dose study. J Am Geriatr Soc 55:234–239120. Murad MH, Elamin KB, Abu Elnour NO, Elamin MB,Alkatib AA, Fatourechi MM, Almandoz JP, Mullan RJ,Lane MA, Liu H, Erwin PJ, Hensrud DD, Montori VM2011 interventions to raise vitamin d level and functionaloutcomes: a systematic review and metaanalysis. J Clin endocrinolMetab121. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M,Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B,Lew RA, Conzelmann M 2003 effects of vitamin d andcalcium supplementation on falls: a randomized controlledtrial. J Bone Miner Res 18:343–351122 Graafmans WC, Ooms ME, Hofstee HM, Bezemer PD,Bouter LM, Lips P 1996 Falls in the elderly: a prospectivestudy of risk factors and risk profiles. am J epidemiol143:1129–1136123. Michael YL, Whitlock EP, Lin JS, Fu R, O’Connor EA,Gold R 2010 Primary care-relevant interventions to preventfalling in older adults: a systematic evidence review for theU.S. Preventive services Task Force. ann intern Med153:815–825124. Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF2009 association between severe vitamin d deficiencyand primary caesarean section. J Clin endocrinol Metab94:940–945125. Holick MF 2006 <strong>Vitamin</strong> d deficiency in obesity andhealth consequences. Curr Opin endocrinol diabetes Obes13:412–418130. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R1998 evidence that vitamin d 3increases serum 25-hydroxyvitamind more efficiently than does vitamin d 2. Am J ClinNutr 68:854–858131. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA 2011<strong>Vitamin</strong> d 3is more potent than vitamin d 2in humans. J ClinEndocrinol Metab 96:E447–E452132. Cesur Y, Caksen H, Gündem A, Kirimi E, Odaba° D 2003Comparison of low and high dose vitaminDtreatment fornutritional vitamin d deficiency rickets. J Pediatr endocrinolMetab 16:1105–1109133. Cagle AP, Waguespack SG, Buckingham BA, Shankar RR,Dimeglio LA 2004 severe infantile hypercalcemia associatedwith Williams syndrome successfully treated with intravenouslyadministered pamidronate. Pediatrics 114:1091–1095134. Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F,Binkley N 2008 Rapid correction of low vitamin d status innursing home residents. Osteoporos Int 19:1621–1628135. Arunabh S, Pollack S, Yeh J, Aloia JF 2003 Body fat contentand 25-hydroxyvitamin d levels in healthy women. J ClinEndocrinol Metab 88:157–161136. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR,Heaney RP 2007 <strong>Vitamin</strong> d and calcium supplementationreduces cancer risk: results of a randomized trial. am J ClinNutr 85:1586–1591137. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E,Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS2008 <strong>Vitamin</strong> d deficiency and risk of cardiovascular disease.Circulation 117:503–511138. Kristal-Boneh E, Froom P, Harari G, Ribak J 1997 associationof calcitriol and blood pressure in normotensive men.Hypertension 30:1289–1294139. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R1990 Myocardial infarction is inversely associated withplasma 25-hydroxyvitamin d3 levels: a community-basedstudy. Int J Epidemiol 19:559–56328
140. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T,Detrano R, Demer LL 1997 active serum vitamin d levelsare inversely correlated with coronary calcification. Circulation96:1755–1760141. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C,Reeve J, Warburton EA 2006 Reduced vitamin d in acutestroke. Stroke 37:243–245142. Elamin MB, Abu Elnour NO, Elamin KB, Murad MH,Fatourechi MM, Alkatib AA, Almandoz JP, Liu H, LaneMA, Mullan RJ, Erwin PJ, Hensrud DD, Montori VM2011 <strong>Vitamin</strong> d supplementation and cardiovascularoutcomes: a systematic review and metaanalysis. J ClinEndocrinol Metab 10.1210/jc.2011-0398143. Grant WB, Cross HS, Garland CF, Gorham ED, Moan J,Peterlik M, Porojnicu AC, Reichrath J, Zittermann A 2009Estimated benefit of increased vitamin d status in reducingthe economic burden of disease in western europe. ProgBiophys Mol Biol 99:104–113E v a l u a t i o n , T r e a t m e n t , a n d P r e v e n t i o n o f V i t a m i n D D e f i c i e n c y29
Change language